Combined modality treatment of anal carcinoma

Oncologist

Volumn 3, Issue 6, 1998, Pages 413-418

  Roelofsen, F ^a   Bartelink, H ^b  

^a Chirurgische Klinik   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Anal carcinoma; Combined modality; Radiochemotherapy; Treatment

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ANUS CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; COLOSTOMY; CONTINUOUS INFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0032432864     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.3-6-413     Document Type: Article

References (19)

1. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354-356.
2. Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984;27:763-766.
3. Nigro ND. Multidisciplinary management of cancer of the anus. World J Surg 1987;11:446-451.
4. Papillon J, Mayer M, Montbarbon JF et al. A new approach to the management of epidermoid carcinoma of the anal canal. Cancer 1983;51:1830-1837.
5. Touboul E, Schlienger M, Buffat L et al. Conservative versus non-conservative treatment of epidermoid carcinoma of the anal canal for tumors longer than or equal to 5 centimeters. A retrospective comparison. Cancer 1995;75:786-793.
6. Michaelson RA, Magill GB, Quan SHOQ et al. Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma. Cancer 1983;51:390-395.
7. Bruckner HW, Spigelman JK, Mandel E et al. Carcinoma of the anus treated with a combination of radiotherapy and chemotherapy. Cancer Treat Rep 1979;63:395-397.
8. Sishy B, Remington JH, Hinson EJ et al. Definitive treatment of anal canal carcinoma by means of radiation therapy and chemotherapy. Dis Colon Rectum 1982;25:685-688.
9. Pipard G, Allal A, Kurtz JM et al. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 1993;27:59-66.
10. Cummings BJ. Anal cancer - radiation alone or with cytotoxic drugs? Int J Radiat Oncol Biol Phys 1993;27:173-175.
11. Cummings BJ, Keane TJ, O'Sullivan B et al. Mitomycin in anal canal carcinoma. Oncology 1993;50:63-69.
12. Bartelink H, Roelofsen F, Eschwege et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal carcinoma: results of a phase III randomized trial of the European Organisation for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-2049.
13. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer, results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin C. Lancet 1996;348:1049-1054.
14. Flam MS, John MJ, Pajak TF et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemo-radiation in the definitive non-surgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-2539.
15. Bosset JF, Pavy JJ, Roelofsen F et al. Combined radiotherapy and chemotherapy for anal cancer. EORTC Radiotherapy and Gastrointestinal Cooperative Groups (Letter). Lancet 1997;349:205-206.
16. Rich TA, Ajani JA, Morrison WH et al. Chemo-radiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 1993;27:209-215.
17. Schaake-Koning C, Van den Bogaert W, Dalesio O et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. New Engl J Med 1992;326:524-530.
18. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
19. Etienne MC, Milano G, Fleming RA et al. L'activité dihydropyrimidine deshydrogénase lymphocytaire: facteur prédictif de la clairance du 5-fluorouracile. Bull Cancer 1992;79:1159-1163.